PHARMACEUTICAL COMPOSITON FOR THE TREATMENT OF POSTHEPATECTOMY LIVER FAILURE AND DISORDER SYMPTOM COMPRISING TERLIPRESSIN OR THE COMBINATION THEREOF

摘要

The present invention relates to a therapeutic agent including terlipressin or a complex formulation of terlipressin as an active ingredient for liver malfunction and hepatosis which are complications occurring after liver operation. A pharmaceutical composition including terlipressin or a complex formulation of terlipressin as an active ingredient has an effect on the treatment of posthepatectomy liver failure or small-for-size syndrome which can occur after liver transplantation, and has an effect on the recovery of liver function or the promotion of recovery.